Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Aug 12, 2024
Date Accepted: Oct 28, 2024

The final, peer-reviewed published version of this preprint can be found here:

Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial

Reback CJ, Blue T, Jalali A, Landovitz RJ, Li MJ, Mata RP, Ryan D, Jeng PJ, Murphy SM

Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2025;14:e65313

DOI: 10.2196/65313

PMID: 39847410

PMCID: 11803334

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women with HIV to Full Viral Suppression (Text Me, Alexis!)

  • Cathy J. Reback; 
  • Thomas Blue; 
  • Ali Jalali; 
  • Raphael J. Landovitz; 
  • Michael J Li; 
  • Raymond P. Mata; 
  • Danielle Ryan; 
  • Philip J. Jeng; 
  • Sean M. Murphy

ABSTRACT

Background:

Many trans women with HIV achieve suboptimal advancement through the HIV Care Continuum, including poor HIV healthcare utilization, retention in HIV medical care, and rates of viral suppression. These issues are exacerbated by comorbid conditions, such as substance use disorder (SUD), which is also associated with reduced quality-of-life, and increased overdose deaths, utilization of high-cost healthcare services, engagement in a street economy, and cycles of incarceration. Thus, it is critical that efforts to End the HIV Epidemic include effective interventions to link and retain trans women in HIV care through full viral suppression.

Objective:

This study builds on the promising findings from our two Health Resources and Services Administration (HRSA)-funded demonstration projects, The Alexis Project and Text Me, Girl!, which utilized Peer Health Navigation (PHN) and SMS (i.e., text messaging), respectively, for advancing trans women with HIV to full viral suppression. Though the effectiveness of both interventions has been established, their comparative-effectiveness, required resources/costs, cost-effectiveness, and heterogeneous effects on subgroups, including those with SUD, have not been evaluated. Given the many negative personal and public-health consequences of untreated/undertreated HIV, and that HIV services for trans women are frequently delivered in resource-limited, community-based settings, a comprehensive economic evaluation is critical to inform decisions of stakeholders, such as providers, insurers, and policymakers.

Methods:

Text Me, Alexis! is a three-arm randomized controlled trial (RCT). Participants (N = 195) will be randomized (1:1:1) into: PHN alone (n = 65), SMS alone (n = 65), or PHN+SMS (n = 65). Using the same time points as the HRSA demonstration projects, the repeated-measures design will assess participants at baseline, 3-, 6-, 12-, and 18-months post-randomization. Over the course of the 90-days, participants in the PHN arm will receive unlimited navigation sessions; participants in the SMS arm will receive 270 theory-based text messages (three messages daily) that are targeted, tailored, and personalized specifically for trans women with HIV; and participants in the PHN+SMS arm will receive a combined PHN and SMS intervention. The desired outcome of Text Me, Alexis! is viral suppression and cost effectiveness.

Results:

Recruitment began on April 10, 2024, and the first participant was enrolled on April 11, 2024. Data collection is expected to be completed in July 2027. Primary outcome analyses will begin immediately following the conclusion of the follow-up evaluations.

Conclusions:

Trans women are a high-priority population for reaching End the HIV Epidemic goals. Findings have the potential to improve individual and population health outcomes by generating significant improvements in viral suppression among trans women and guiding service provision and public policy.


 Citation

Please cite as:

Reback CJ, Blue T, Jalali A, Landovitz RJ, Li MJ, Mata RP, Ryan D, Jeng PJ, Murphy SM

Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2025;14:e65313

DOI: 10.2196/65313

PMID: 39847410

PMCID: 11803334

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.